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Cardiovascular disease is the primary cause of morbidity and mortality in developing countries. According to Fetal origin’s Hypothesis proposed by David Barker “intrauterine 
growth retardation, low birth weight (LBW) and premature birth 
have a causal relationship to the origins of hypertension (HTN), 
coronary heart disease in middle age” [1]. Premature and growth-
restricted neonates are unable to accumulate glycogen deposits in the 
later part of pregnancy leading to activation of lipid metabolism for 
promoting gluconeogenesis and generating energy. As a result, these 
neonates have abnormal lipid profile compared to appropriate for 
gestational age (AGA) babies, thus predisposing them to coronary 
heart disease, HTN, and Type 2 diabetes mellitus later in life [2]. 
Keeping in view the fact that nearly one-third neonates born in 
India are LBW, of which two-thirds are having intrauterine growth 
restriction (IUGR) [3] and also the malnutrition profile of pregnant 
women in India, this study was undertaken to document the variable 
neonatal lipid profile with respect to GA, birth weight, and sex.
METHODS
This hospital-based, prospective, and observational study was 
conducted in the department of paediatrics of a tertiary care 
teaching hospital from January 2017 to July 2018 involving 
in-house delivered 1000 neonates. As it was a time-bound study, 
a sample size of 1000 neonates was considered by convenient 
sampling method. The consent for participation in this study 
was obtained at birth from parents or attendants. The GA was 
determined based on last menstrual period (LMP) and confirmed 
using criteria described by New Ballard Score [4]. Fenton’s 
growth charts were utilized to classify study subjects as AGA, 
small for GA (SGA), and large for GA (LGA) at birth.
All neonates born to mothers with definitely known LMP and 
Ballard score correlation <2 weeks and delivered between 28 and 
42 weeks of gestation were included in the study. Neonates with 
congenital malformations, suspected sepsis, and Apgar score <7 at 
5 min were excluded from the study. 2.5 ml of cord blood sample 
was collected from the placental end of the cord just after the 
delivery of the baby in a plane dry test tube, and lipid profile was 
assessed employing Humastar 200® Biochemical Analyzer based 
on the principle of enzymatic colorimetry. Serum low-density 
lipoprotein (LDL) was derived after estimating total cholesterol, 
high-density lipoprotein (HDL) cholesterol, triglycerides (TG) 
concentration, and deploying them in Friedewald’s formula: LDL 
cholesterol (LDL-C) (mg/dl) = total cholesterol (mg/dl) – HDL 
cholesterol (mg/dl) – TG (mg/dl) ∕ 5.
All relevant statistical analysis was performed using SPSS 
Version 21.0 statistical analysis software. This study was approved 
by the Institutional Ethics Committee.
ABSTRACT
Objectives: The objective of the study was to compare the cord blood lipid levels in healthy newborns according to gestational 
age (GA), weight, and sex. Methods: This study included 1000 healthy term and preterm neonates after obtaining parental consent 
at birth. The GA was confirmed using New Ballard Score. Fenton’s growth charts were utilized to classify study subjects as 
appropriate for GA, small for GA, and large for GA at birth. Lipid profile was measured by enzymatic colorimetric method. 
Serum low-density lipoprotein-cholesterol (LDL-C) was calculated by Friedewald’s formula. Results: Preterm neonates with GA 
of 28–36 weeks had higher mean total cholesterol, LDL, very LDL, and triglycerides levels than term neonates in contrast to their 
mean high-density lipoprotein (HDL) levels which was significantly lower as compared to that of term neonates. A statistically 
significant decline in all lipid fractions was observed with an increase in birth weight from <1.5 kg to ≥2.5 kg. Females had higher 
lipid fractions in comparison to male neonates; however, only the difference in HDL levels was statistically significant (p<0.001). 
Conclusion: Low birth weight neonates exhibit higher lipid levels at birth giving scope for future research and regular follow-up 
of these high-risk neonates.
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RESULTS
Out of 1000 neonates enrolled in the study, 511 (51.1%) were 
males and 489 (48.9%) were females and male:female ratio was 
1.04:1. The most common GA was 37–40 weeks (55.7%) followed 
by 28–36 weeks (35.4%) and 40–42 weeks (8.9%). The majority 
(64%) of the neonates enrolled in the study was AGA followed 
by 29.5% neonates who were SGA and 6.5% neonates who were 
LGA. The birth weight of majority (60.6%) of the neonates was 
>2.5 kg followed by neonates having weight 1.5–2.5 kg (38.4%) 
and <1.5 kg (1%). The mean total cholesterol, LDL, HDL, TG, 
and very LDL (VLDL) levels were found to be significantly 
higher in neonates with GA of 28–36 weeks in comparison to 
neonates with GA of 37–40 weeks (Tables 1 and 2).
The absolute mean levels of total cholesterol, LDL, and TG in 
neonates with GA of 28–36 weeks were found to be significantly 
higher than in neonates of 37–40 weeks GA in contrast to HDL 
levels which were significantly higher in 37–40 week neonates as 
compared to neonates in 28–36 weeks category. Total cholesterol 
and LDL levels were also found to be significantly higher in 
40–42 weeks GA neonates in comparison to neonates with GA 
of 37–40 weeks. A statistically significant decline in all lipid 
fractions was observed with an increase in birth weight from 
<1.5 kg to ≥2.5 kg (Tables 3 and 4).
All lipid fractions were numerically elevated in SGA as 
compared to AGA neonates, but on the comparison, only levels 
of LDL and HDL were statistically significant. As compared to 
AGA, LGA neonates exhibited significantly elevated levels of 
total cholesterol, TG, and VLDL (Tables 5 and 6).
The absolute concentration of all components of the lipid 
profile was higher in females as compared to males (Fig. 1), 
but only the mean HDL level was found statistically significant 
(p<0.001).
DISCUSSION
Lipid levels are a recognized marker for cardiovascular risk as 
early identification of lipid dysfunction helps to avert the risk 
by appropriate interventions. The usefulness of lipid levels in 
assessment of cardiovascular risk among adults has motivated 
researchers to search whether they hold any relevance in childhood 
and for that matter to check whether, at birth, lipid levels hold any 
significance at all. This study was conducted to compare lipid 
levels in neonates to identify high-risk neonates susceptible to 
develop cardiovascular disease in adulthood.
The proportional distribution of neonates with different 
GAs at birth has shown a tremendous variability in different 
studies performed on lipid levels in the past. In the present 
study, both preterm and late-term (40–42 weeks) neonates were 
included. However, some workers had focused only on normal 
term newborns with GA at birth between 37 and 40 weeks [5,6]. 
Some studies that included both preterm and term neonates 
reported the proportion of term to be higher [7,8]. There are 
some studies that have been conducted using a purposive 
Table 1: Comparison of the lipid profile of study subjects with respect to gestational age
Lipid profile 28–36 weeks (n=354) 37–40 weeks (n=557) 40–42 weeks (n=89) p values
Mean±SD (95% CI)
Total cholesterol 79.01±13.82 (72.3–94.9) 62.87±15.03 (61.6–64.1) 70.83±20.54 (66.5–75.16) <0.001
LDL 47.21±7.92 (43.3–52.5) 31.32±16.55 (29.9–32.6) 39.42±15.79 (36.1–42.7) <0.001
HDL 23.49±8.75 (14.0–34.8) 24.34±8.54 (24.6–25.6) 23.49±9.53 (21.4–25.5) <0.051
Triglyceride 43.37±15.4 (29.0–64.4) 36.87±13.32 (35.7–37.9) 39.56±13.94 (36.6–42.5) 0.003
VLDL 8.68±3.09 (5.96–12.9) 7.37±2.66 (7.15–7.60) 7.90±2.79 (7.33–8.50) 0.003
LDL: Low‑density lipoprotein, HDL: High‑density lipoprotein, VLDL: Very low‑density lipoprotein, SD: Standard deviation, CI: Confidence interval
Table 2: Significance of differences between gestational ages – P values
Gestational age (in weeks) Total cholesterol LDL HDL Triglycerides VLDL
28–36 versus 37–40 <0.001 <0.001 <0.001 0.010 0.010
28–36 versus 40–42 0.148 0.301 0.975 0.449 0.449
37–40 versus 40–42 <0.001 <0.001 0.451 0.270 0.270
LDL: Low‑density lipoprotein, HDL: High‑density lipoprotein, VLDL: Very low‑density lipoprotein
Table 3: Comparison of the lipid profile of study subjects with respect to birth weight
Lipid profile <1.5 kg (n=10) 1.5–2.5 kg (n=384) >2.5 kg (n=606) p value
Mean±SD (95% CI)
Total cholesterol 94.88±3.26 (93.2–96.5) 75.52±17.87 (69.5–84.8) 63.54±15.42 (62.3–64.7) <0.001
LDL 56.79±5.69 (53.8–59.7) 44.54±16.19 (40.1–51.7) 32.48±15.56 (31.2–33.7) <0.001
HDL 29.53±5.28 (26.8–32.2) 23.03±8.16 (21.2–25.5) 24.34±8.74 (23.6–25.0) 0.001
Triglyceride 42.82±9.00 (38.2–47.4) 42.12±13.86 (37.6–48.7) 36.75±12.7 (35.7–37.7) <0.001
VLDL 8.56±1.80 (7.6–9.4) 8.42±2.77 (7.5–9.7) 7.30±2.55 (7.1–7.5) <0.001
LDL: Low‑density lipoprotein, HDL: High‑density lipoprotein, VLDL: Very low‑density lipoprotein, SD: Standard deviation, CI: Confidence interval
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sampling design that has included neonates with different GAs 
in an equal number [9,10].
The present study had a gender ratio of 1.04:1 indicating 
relatively higher male study subjects as compared to females. In 
different contemporary studies from India, the gender ratio shows 
a predominance of males over females. Sreekarthik et al. (1.5:1), 
Mishra et al. (1.17:1), and Murthy et al. (1.13:1) reported the male 
dominance [8,11,12]. However, a study by Kharb et al. exhibited 
equal participation of both sexes and other study by Kenchappa 
and Behera reported female predominance [13,14].
On overall evaluation, no significant gender differences were 
observed in total cholesterol, triglyceride, and VLDL levels; 
however, HDL levels were found to be significantly higher in 
females as compared to males, which is in consonance with other 
studies [11,13,15,16]. However, a few studies did not find any 
significant difference between the two genders [17-19]. As most 
of the previous studies have been carried out on a small sample 
size wherein gender differences could not have been substantiated 
statistically; nevertheless, this finding needs further corroboration 
on larger sample size.
Table 4: Significance of differences between birth weights – p values
Birth weight (in kg) Total cholesterol LDL HDL Triglycerides VLDL
<1.5 versus 1.5–2.5 <0.001 0.001 0.005 0.647 0.647
<1.5 versus >2.5 <0.001 <0.001 0.054 0.224 0.224
1.5–2.5 versus >2.5 <0.001 <0.001 0.825 <0.001 <0.001
LDL: Low‑density lipoprotein, HDL: High‑density lipoprotein, VLDL: Very low‑density lipoprotein
Table 5: Comparison of the lipid profile of study subjects with respect to growth status at birth
Lipid profile SGA (n=295) AGA (n=640) LGA (n=65) p value
Mean±SD (95% CI)
Total cholesterol 69.69±20.5 (67.3–72.0) 66.50±14.74 (65.3–67.6) 68.9±15.02 (65.2–72.6) 0.020
LDL 37.95±18.1 (35.8–40.0) 35.84±15.72 (34.6–37.0) 41.4±11.63 (34.5–44.2) 0.012
HDL 24.30±8.50 (23.3–25.2) 23.99±8.39 (23.3–24.6) 20.1±6.42 (18.5–21.7) 0.001
Triglyceride 39.86±13.6 (38.2–41.4) 37.07±12.26 (36.1–38.0) 41.0±16.95 (36.8–45.2) 0.002
VLDL 7.97±2.73 (7.66–8.29) 7.41±2.45 (7.22–7.60) 8.20±3.39 (7.36–9.04 0.002
LDL: Low‑density lipoprotein, HDL: High‑density lipoprotein, VLDL: Very low‑density lipoprotein, SD: Standard deviation, CI: Confidence interval, SGA: Small for gestational 
age, AGA: Appropriate for gestational age, LGA: Large for gestational age
Table 6: Significance of differences between growth status – p values
Growth status at birth Total cholesterol LDL HDL Triglycerides VLDL
LGA versus AGA 0.018 0.154 0.850 0.007 0.007
LGA versus SGA 0.944 0.268 0.001 0.794 0.794
AGA versus SGA 0.495 0.023 0.001 0.052 0.052
LDL: Low‑density lipoprotein, HDL: High‑density lipoprotein, VLDL: Very low‑density lipoprotein, SGA: Small for gestational age, AGA: Appropriate for gestational age, 
LGA: Large for gestational age
Figure 1: Comparison of the lipid profile of study subjects with respect to gender
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In this study, with increasing birth weight category, mean cord 
blood lipid levels (except HDL) showed a significant decline 
whereas mean HDL levels were found to be higher in birth weight 
category >2.5kg as compared to neonates with birth weight in 
the range of 1.5–2.5 kg. The relationship between birth weight 
and lipid levels has been found to be similar as observed for GA, 
i.e. with increasing birth weight; there is a significant decline in 
total cholesterol, LDL, TG, and VLDL levels except for HDL 
levels. However, contrary to the present study, Donegá et al. [17] 
and Esfarjani et al. [20] did not find a significant association 
between lipid levels and birth weight. Kelishadi et al. [15], on the 
other hand, found a correlation between birth weight and high cord 
triglyceride levels. Aletayeb et al. [18] found both LBW (<2.5 kg) 
and high birth weight (>4.0 kg) to be associated with significantly 
higher mean triglyceride, total cholesterol, LDL, and VLDL levels 
as compared to those in the normal birth weight category. Another 
study from India, having a high representation of neonates with 
birth weight >4 kg (32%) showed a positive correlation between 
birth weight and total cholesterol, Triglyceride, HDL, and VLDL 
levels but an inverse correlation between birth weight and LDL 
levels. Incidentally, in the present study, there was no category 
of >4 kg. In fact, we had only 3 (0.3%) neonates with birth 
weight >3.5 kg; hence, we are not in a position to comment 
over that. However, this relationship needs further exploration 
as it is reported only by a few studies and generally, there is an 
inverse trend between lipid levels (except HDL) and birth weight. 
A similar observation was also made for triglyceride levels by 
Ramy et al. [21]. A number of Indian studies have also supported 
the findings of the present study [14,22].
In this study, a binomial trend in lipid levels was observed. It 
was evident that lipid levels (total cholesterol, LDL, and HDL) 
of neonates with GA 37–40 weeks (term) were significantly 
lesser than those observed in both preterm and late-term (40–
42 weeks). Pardo et al. [6] found lipid levels of near-term (34–
36 weeks) newborns to be significantly higher as compared to 
term newborns, whereas, Ghaemi et al. [23], similar to the present 
study, found mean triglyceride, cholesterol, and LDL levels of 
preterm and near term newborns to be significantly higher as 
compared to term newborns. This finding is also in agreement 
with other studies [24]. This may be most likely due to its rapid 
uptake and metabolism of LDL by the fetal adrenal as precursor or 
substrate for steroid hormone synthesis with further progression 
in gestation as postulated by Parker et al. [25]. The mean HDL 
levels were significantly higher in full-term as compared to 
premature neonates. Spear et al. [26] demonstrated that the 
lecithin-cholesterol acyltransferase (LCAT) activity was lower 
in the near term than in term neonates. Hence, fall in HDL may 
be associated with an increase in the activity of LCAT activity 
during intrauterine life of the fetus.
In this study, on comparing the lipid levels among neonates 
with different growth status (SGA, AGA, and LGA), differences 
were seen for HDL levels which were significantly higher in SGA 
followed by AGA as compared to LGA neonates. Ramy et al. [24] 
and Lobo et al. [27] observed that mean levels of TG and LDL 
were significantly higher in the SGA compared with the AGA 
and significantly higher in the AGA compared with the LGA, 
respectively, which was in consonance with the present study. 
Katragadda et al. [7] found that the mean triglyceride and VLDL 
levels of preterm SGA babies were significantly higher as compared 
to AGA babies, which was again in consonance with this study. 
Contrasting results were seen by Jadhao et al. [19] who did not find 
any significant difference in lipid levels between SGA and AGA 
babies. Kelishadi et al. [15] found mean LDL-C and HDL-C of LGA 
were significantly lower compared with AGA and SGA neonates. 
A shortcoming of their study was that SGA comprised only 9.2% 
of their study population (n=35), and it would be inappropriate to 
generalize their trends, obtained on the basis of such a small sample 
size. As such most of the studies have compared the lipid levels 
between SGA and AGA babies only. Thus, the generalized trend 
indicates that SGA babies have a tendency to acquire higher lipid 
values as compared to AGA babies.
The strengths of this study were larger sample size as 
compared to other studies and reduced selection bias by enrolling 
consecutive newborns delivered in this hospital. This study 
had certain limitations. As it was a time-bound study; hence, 
a convenient sample size of 1000 neonates was considered 
as representative of a local rural population which may not 
render adequate power to this study. Further, antenatal maternal 
comorbidities (HTN, obesity, and diabetes) and lipid profile were 
not taken into consideration. Many mothers were not on regular 
antenatal monitoring, which impeded the accuracy of variables 
such as body mass index, maternal weight gain, hemoglobin 
levels, placental histopathology, fetal middle cerebral arterial 
Doppler assessment, and symmetric versus an asymmetric pattern 
of IUGR in SGA babies. Further, correlation with their lipid 
profile could not be performed owing to resource constraints. 
No, follow-up was performed to see the changes in lipid levels 
with age.
It may thus be hypothesized that SGA babies and premature 
babies due to higher lipid levels (except HDL) at birth are 
predisposed to develop atherosclerosis and coronary heart disease 
later in life, thus mandating regular monitoring of their lipid levels 
during childhood and adolescence.
CONCLUSION
As observed, all lipid fractions except HDL are higher in LBW 
babies as compared to term AGA babies, and the HDL fraction is 
relatively higher in the AGA than in the SGA. It is recommended 
that further prospective cohort studies need to be performed 
in LBW babies to monitor serum lipid levels and subsequent 
development of atherosclerotic lesions in adulthood.
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